Biovie Inc (BIVI) Stock Price, Quote & News

Company Profile

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as fo...

Industry: Biotechnology

Sector: Healthcare

Phone: 775 888 3162

Website: bioviepharma.com

Address:

680 W. Nye Lane, Suite 204, Carson City, United States

Ge_ne_tics Oct. 6 at 11:32 PM

$BIVI still in this. $2+ consolidation then breakout

0 · Reply

yus37 Oct. 6 at 2:42 PM

$BIVI $PSTV $XBI

0 · Reply

Vikingsstrade Oct. 3 at 7:24 PM

Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $LRHC $FLYE $BIVI $WBX

0 · Reply

MoonCowBoy Oct. 2 at 11:55 PM

$LVLU $LRHC $BIVI $

0 · Reply

wahoowa96 Oct. 2 at 12:59 AM

$BIVI What happened about a year ago? Blew up a trial?

0 · Reply

_2025 Oct. 1 at 7:56 PM

$BINI @Sensore Thank you for 130% for $DVLT Thank you for 95% for YCBD Thank you for 280% for THAR Thank you for all trades Next to skyrocket OP, $BIVI, ZNB, BINI Sensore you are #1

0 · Reply

yus37 Oct. 1 at 5:54 PM

$BIVI $XBI ......

1 · Reply

CalculatedSwing Oct. 1 at 4:02 PM

$BIVI 🚀 $BIVI heating up ahead of Oct 8 investor webinar—analysts flash Strong Buy with $16 PT from $1.90! Neuro pipeline crushing it on Alzheimer's & Parkinson's breakthroughs. Newbies, this is prime time to go all in for massive gains! 🌕 Tagging the neuro squad: $SAVA $ANVS $INMB $PRTA #Biotech #Neuro #AllIn

0 · Reply

Tradebait88 Sep. 30 at 1:38 PM

$BIVI wedge on chart looks like news soon

1 · Reply

Sensore Sep. 26 at 4:59 PM

$BIVI ..

0 · Reply

BioVie to Host Live Investor Webinar and Q&A on Oct. 8

Aug 13, 2025, 4:05 PM EDT - 7 weeks ago

BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes

Aug 7, 2025, 8:43 PM EDT - 2 months ago

BioVie Inc. Announces Pricing of $12 Million Public Offering

Jul 24, 2025, 8:00 AM EDT - 2 months ago

BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology

Jul 22, 2025, 8:00 AM EDT - 2 months ago

BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors

Jun 26, 2025, 8:00 AM EDT - 3 months ago

BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)

Jun 24, 2025, 4:05 PM EDT - 3 months ago

BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress

May 14, 2025, 7:30 AM EDT - 5 months ago

BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025

Mar 27, 2025, 8:00 AM EDT - 6 months ago

BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025

Jan 26, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Shareholders to Inquire about Securities Investigation

Jan 22, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Shareholders to Connect

Jan 19, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Shareholders to Reach Out

Jan 15, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Shareholders to Learn More About the Investigation

Jan 12, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Investors to Learn More About the Investigation

Jan 8, 2025, 10:00 AM EST - 9 months ago

BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Investors to Connect

Jan 2, 2025, 10:00 AM EST - 9 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Stockholders to Inquire about Securities Investigation

Dec 24, 2024, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out

Dec 22, 2024, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Stockholders to Reach Out

Dec 18, 2024, 10:00 AM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Stockholders to Connect

Dec 15, 2024, 10:00 AM EST - 10 months ago

BioVie Inc. (BIVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Dec 11, 2024, 2:00 PM EST - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against BioVie Inc. (BIVI) and Encourages Stockholders to Learn More About the Investigation

Oct 28, 2024, 4:10 PM EDT - 1 year ago

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 28, 2024, 3:13 PM EDT - 1 year ago

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 24, 2024, 4:10 PM EDT - 1 year ago

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement

Oct 23, 2024, 3:24 PM EDT - 1 year ago

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 15, 2024, 8:00 AM EDT - 1 year ago

BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin

Oct 11, 2024, 9:00 AM EDT - 1 year ago

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GENE

Sep 25, 2024, 4:05 PM EDT - 1 year ago

BioVie Inc. Announces Closing of Public Offering

Sep 24, 2024, 2:08 PM EDT - 1 year ago

Crude Oil Gains Over 1%; BioVie Shares Plunge

Sep 23, 2024, 10:26 PM EDT - 1 year ago

BioVie Inc. Announces Pricing of Public Offering

Sep 23, 2024, 4:05 PM EDT - 1 year ago

BioVie Inc. Announces Proposed Public Offering

Sep 16, 2024, 8:00 AM EDT - 1 year ago

BioVie Secures All Scientific Approvals Needed to Receive Additional $12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Long COVID

Sep 3, 2024, 8:00 AM EDT - 1 year ago

BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID

Aug 27, 2024, 8:45 AM EDT - 1 year ago

BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting

Aug 8, 2024, 6:00 AM EDT - 1 year ago

BioVie Announces Alignment with FDA on Clinical Trial to Assess Bezisterim in Parkinson's Disease

Aug 6, 2024, 4:40 PM EDT - 1 year ago

BioVie Inc. Announces Reverse Stock Split

Jul 5, 2024, 9:00 AM EDT - 1 year ago

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

BIAF

Jun 21, 2024, 9:00 AM EDT - 1 year ago

BioVie and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

MOB

Jun 20, 2024, 8:00 AM EDT - 1 year ago

BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson's Disease at 2024 ATMRD Congress

Jun 12, 2024, 8:24 AM EDT - 1 year ago

Join BioVie's Exclusive Live Investor Webinar and Q&A Session on June 26

May 22, 2024, 8:00 AM EDT - 1 year ago

BioVie's Bezisterim Demonstrates Potential Improvements in Sleep/Fatigue and Restless Leg Symptoms for Parkinson's Disease Patients

Apr 29, 2024, 8:00 AM EDT - 1 year ago

BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID

Apr 25, 2024, 8:00 AM EDT - 1 year ago

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer's Disease and Biomarker Endpoints

Apr 18, 2024, 8:00 AM EDT - 1 year ago

BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

Apr 12, 2024, 9:00 AM EDT - 1 year ago

Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GENE

Mar 26, 2024, 10:30 AM EDT - 1 year ago

Lawsuit Notice: Investors who lost money with BioVie Inc. (NASDAQ: BIVI) shares should contact the Shareholders Foundation

Mar 19, 2024, 7:00 AM EDT - 1 year ago

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in BioVie Inc. with Losses of $100,000 to Contact the Firm

Ge_ne_tics Oct. 6 at 11:32 PM

$BIVI still in this. $2+ consolidation then breakout

0 · Reply

yus37 Oct. 6 at 2:42 PM

$BIVI $PSTV $XBI

0 · Reply

Vikingsstrade Oct. 3 at 7:24 PM

0 · Reply

MoonCowBoy Oct. 2 at 11:55 PM

$LVLU $LRHC $BIVI $

0 · Reply

wahoowa96 Oct. 2 at 12:59 AM

$BIVI What happened about a year ago? Blew up a trial?

0 · Reply

_2025 Oct. 1 at 7:56 PM

$BINI @Sensore Thank you for 130% for $DVLT Thank you for 95% for YCBD Thank you for 280% for THAR Thank you for all trades Next to skyrocket OP, $BIVI, ZNB, BINI Sensore you are #1

0 · Reply

yus37 Oct. 1 at 5:54 PM

$BIVI $XBI ......

1 · Reply

CalculatedSwing Oct. 1 at 4:02 PM

0 · Reply

Tradebait88 Sep. 30 at 1:38 PM

$BIVI wedge on chart looks like news soon

1 · Reply

Sensore Sep. 26 at 4:59 PM

$BIVI ..

0 · Reply

TJ12000 Sep. 26 at 11:49 AM

$BIVI Kong gone incognito with this scam…class action marches ahead #snake oil

0 · Reply

Holymoly1269 Sep. 25 at 1:45 PM

$BIVI $1.50 to buy

1 · Reply

TJ12000 Sep. 24 at 10:08 PM

$BIVI when’s the last time that greaseball snake oil salesman bought this scam?!

0 · Reply

Thorilium Sep. 24 at 10:29 AM

$BIVI nice this woke up...but not like ICU and I expect also to see some SP jump at CYDY All these stocks are into inflammation. Interesting

0 · Reply

Thorilium Sep. 23 at 6:54 AM

$ICU Point is this is an unknown stock that soon will appear in everyones trading portfolio And those investers into inflammation will be highly interested as Well Imo could be some combo therapies also ai confirms ☺️ $CYDY $BIVI

1 · Reply

Ge_ne_tics Sep. 19 at 10:44 PM

$BIVI just consolidated in the 1.80 - 1.90. Take a look at $AGMH last 30 day just consolidating then boom hit $15+. Same thing will happen with BIVI. Post RS low float. Just waiting for news to breakout. Do your own DD.

0 · Reply

ImATraderBro Sep. 19 at 5:00 PM

$BIVI lookong for 40%

0 · Reply

Lawndude Sep. 19 at 4:53 PM

$BIVI this is a garbage stock don’t get sucked in they robbed me of over $40,000. It’s total garbage they should sell already leadership has failed.

2 · Reply

Rod75b15 Sep. 19 at 12:37 PM

$BIVI

0 · Reply

toccoc Sep. 19 at 12:47 AM

$BIVI SOON

0 · Reply

CalculatedSwing Sep. 18 at 3:24 AM

🚀 My degen portfolio is on FIRE with these undervalued beasts under $2 (except one powerhouse)! $GLMD $1.36: Aramchol biomarkers unlocking oncology goldmines, 378% to $6.50 targets! $SVRE $1.65: ADAS VRU deals equipping millions of cars, safety tech exploding! $GFAI $1.16: AI security in Thailand + gov't renewals, $4.50 PT for 300% pop! $EU $1.59: Uranium ISR ramp to 1.5M lbs/yr on AI nuke demand, $5.25 upside! $NNVC $1.45: NV-387 antiviral crushing trials for RSV/COVID, Phase II catalysts ahead! $BIVI $1.75: Neuro therapies for Alzheimer's/Parkinson's, analysts eyeing $16+! & $CORZ $16.21: HPC pivot + CoreWeave deal smashing Q2, $22 PT in crypto/AI surge! Portfolio primed for 5-10x liftoff—loading up! #PennyStocks #Biotech #Uranium #AI $LEXX $TNXP $URG $MARA

0 · Reply

CalculatedSwing Sep. 17 at 7:40 PM

$EU Just getting started. End position will be 200k shares. $ONDS $AXTI $GLMD $BIVI $SOUN

1 · Reply

Market Cap	14.69M
Revenue (ttm)	0.00
Net Income (ttm)	-17.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	306,800
Avg Vol	337,526
Day's Range	N/A - N/A
Shares Out	7.54M
Stochastic %K	40%
Beta	0.71
Analysts	Sell
Price Target	$12.00